RT Journal Article
SR Electronic
T1 The Challenge of Forecasting Demand of Medical Resources and Supplies During a Pandemic: A Comparative Evaluation of Three Surge Calculators for COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.29.20204172
DO 10.1101/2020.09.29.20204172
A1 Kamar, A.A.
A1 Maalouf, N.
A1 Hitti, E.
A1 Eid, G. El
A1 Isma’eel, H.
A1 Elhajj, I. H.
YR 2020
UL http://medrxiv.org/content/early/2020/09/30/2020.09.29.20204172.abstract
AB Ever since the World Health Organization (WHO) declared the new coronavirus disease 2019 (COVID-19) as a pandemic, there has been a public health debate concerning medical resources and supplies including hospital beds, intensive care units (ICU), ventilators, and Protective Personal Equipment (PPE). Forecasting COVID-19 dissemination has played a key role in informing healthcare professionals and governments on how to manage overburdened healthcare systems. However, forecasting during the pandemic remained challenging and sometimes highly controversial. Here, we highlight this challenge by performing a comparative evaluation for the estimations obtained from three COVID-19 surge calculators under different social distancing approaches, taking Lebanon as a case study. Despite discrepancies in estimations, the three surge calculators used herein agree that there will be a relative shortage in the capacity of medical resources and a significant surge in PPE demand as the social distancing policy is removed. Our results underscore the importance of implementing containment interventions including social distancing in alleviating the demand for medical care during the COVID-19 pandemic in the absence of any medication or vaccine. It is said that “All models are wrong, but some are useful,” in this paper we highlight that it is even more useful to employ several models.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding availableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB needed since there are no human subjects usedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequests for access to the data that support this study should be made to the corresponding Authors Dr. Hussain Ismaeel and Dr. Imad Elhajj.